University of Texas: Five Months After FDA Ban, New Study Finds Alternate Procedure Comparable to Hysterectomy
September 18, 2019
September 18, 2019
AUSTIN, Texas, Sept. 18 [TNSmedicalresearch] -- The University of Texas issued the following news release:
Five months after the U.S. Food and Drug Administration halted the sale of kits used to correct a common pelvic floor problem in women known as uterovaginal prolapse, novel research published in the Journal of the American Medical Association shows patient results from the procedure generally are positive and comparable to those of their common alternative, hysterectomy with va . . .
Five months after the U.S. Food and Drug Administration halted the sale of kits used to correct a common pelvic floor problem in women known as uterovaginal prolapse, novel research published in the Journal of the American Medical Association shows patient results from the procedure generally are positive and comparable to those of their common alternative, hysterectomy with va . . .